Page last updated: 2024-10-29

itraconazole and Aspergillosis

itraconazole has been researched along with Aspergillosis in 11 studies

Aspergillosis: Infections with fungi of the genus ASPERGILLUS.

Research Excerpts

ExcerptRelevanceReference
"Oral posaconazole therapy was started 24 h after infection and was given once daily for 14 consecutive days."1.36Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. ( Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE, 2010)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's8 (72.73)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartroli, J2
Turmo, E2
Algueró, M2
Boncompte, E2
Vericat, ML2
Conte, L2
Ramis, J2
Merlos, M2
García-Rafanell, J2
Forn, J2
Ohwada, J1
Tsukazaki, M1
Hayase, T1
Oikawa, N1
Isshiki, Y1
Fukuda, H1
Mizuguchi, E1
Sakaitani, M1
Shiratori, Y1
Yamazaki, T1
Ichihara, S1
Umeda, I1
Shimma, N1
Fritsche, TR1
Rhomberg, PR1
Sader, HS1
Jones, RN1
Troke, P1
Aguirrebengoa, K1
Arteaga, C1
Ellis, D1
Heath, CH1
Lutsar, I1
Rovira, M1
Nguyen, Q1
Slavin, M1
Chen, SC1
Rodriguez-Tudela, JL2
Alcazar-Fuoli, L1
Mellado, E1
Alastruey-Izquierdo, A2
Monzon, A1
Cuenca-Estrella, M2
Seidler, MJ1
Salvenmoser, S1
Müller, FM1
Lass-Flörl, C2
Perkhofer, S1
Arendrup, MC1
Garcia-Effron, G1
Buzina, W1
Mortensen, KL1
Reiter, N1
Lundin, C1
Jensen, HE1
Perlin, DS1
Bruun, B1
Beernaert, LA1
Pasmans, F1
Van Waeyenberghe, L1
Dorrestein, GM1
Verstappen, F1
Vercammen, F1
Haesebrouck, F1
Martel, A1
Mavridou, E1
Brüggemann, RJ1
Melchers, WJ1
Mouton, JW1
Verweij, PE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. A Prospective Multicenter Observational Study.[NCT03121235]320 participants (Actual)Observational2017-04-20Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

11 other studies available for itraconazole and Aspergillosis

ArticleYear
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
    Journal of medicinal chemistry, 1998, May-21, Volume: 41, Issue:11

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi

1998
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
    Journal of medicinal chemistry, 1998, May-21, Volume: 41, Issue:11

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi

1998
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
    Bioorganic & medicinal chemistry letters, 2003, Jan-20, Volume: 13, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Biotransformation; Candidiasis; Chemical Phenomena; Chemi

2003
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis

2008
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschoo

2008
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome

2008
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic

2008
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soi

2009
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Cas

2009
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergi

2009
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumig

2010